ACCL (ACCL) Stock Price & Analysis
ACCL (ACCL) fell 2.14% to USD 2.74 as of September 8, 2026 at 10:18 UTC, according to Nexqual real-time market data.
ACCL last closed at USD 2.74; the session ranged USD 2.74–2.74 on volume of 3,930 shares. Market capitalization is —, with a 52-week range of USD 1.23–5 (NCM). Source: Nexqual, September 8, 2026 at 10:18 UTC.
Key Statistics (as of September 8, 2026 at 10:18 UTC)
| Price | USD 2.74 |
|---|---|
| Change | ▼ 2.14% (down) |
| Previous Close | USD 2.74 |
| Open | USD 2.74 |
| Day Range | USD 2.74 – 2.74 |
| 52-Week Range | USD 1.23 – 5 |
| Volume | 3,930 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ACCL)
Nexqual's technical model rates ACCL "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 10:18 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.86 (neutral) |
| vs SMA50 | Above (USD 2.38) |
| MACD | 0.11 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLSN | Solesence, Inc. | USD 0.85 | ▼ 6.7% |
| SKYE | Skye Bioscience, Inc. | USD 1.86 | ▲ 1.09% |
| NVEC | NVE Corporation | USD 100.4 | ▲ 1.93% |
| ALTI | AlTi Global, Inc. | USD 3 | ▼ 22.88% |
| VECO | Veeco Instruments Inc. | USD 44.67 | ▲ 3.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:18 UTC. This page is informational and not investment advice.